Atlas Trials

Allo-PBSCT as the First-line Treatment for Patients With the High-risk PTCL

Clinical trial NCT06509945 · UNKNOWN

Trial details

NCT number
NCT06509945
Sponsor
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Peripheral T Cell Lymphoma
Start date
2024-07-15
Primary completion
2026-07-15
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.